Lancashire and South Cumbria Haematology CRG

Haematology CRG Chair: Dr Mark Grey, Consultant Haematologist, Blackpool Teaching Hospitals NHS Foundation Trust

Secretary: Danielle Wilkinson danielle.wilkinson10@nhs.net
CRG Group Contact: Rachel Ellis Rachel.Ellis@LTHTR.nhs.uk

The role and purpose of the Haematology CRG is to improve the experience and outcomes of cancer care for haematology patients in Lancashire & South Cumbria.
This involves consideration of strategies and plans for service improvement and service development across the patient pathway, incorporating all aspects of care at appropriate stages of the patient's journey. The aim is to achieve the best possible outcomes and best quality of life for all patients who use haematological cancer services within the Alliance.

Members of the CRG will be responsible for feeding back information/decisions from the CRG to their clinical and managerial colleagues.

Haematology CRG Key Documents

LSCCA Burkitt's and Burkitt's - Like Lymphoma Guidelines (Updated December 2022) LSCCA Chronic Lymphocytic Leukaemia Guidelines (Updated April 2022) LSCCA Diffuse Large B-cell Lymphoma Guidelines (Updated July 2020) LSCCA Essential Thrombocythaemia Guidance (Updated February 2022) LSCCA Follicular Lymphoma Guidelines (Updated October 2021) LSCCA Hairy Cell Leukaemia (HCL) and HCL Variant (HCL-V) Guidelines (Updated April 2022) LSCCA Hodgkin's Lymphoma Guidelines (Updated October 2020) LSCCA Mantle Cell Lymphoma Guidelines (Updated February 2022) LSCCA Myeloma Guidelines (Updated March 2021) LSCCA Polycythaemia Vera Guidelines (Updated February 2022) LSCCA Primary Myelofibrosis Guidelines (Updated February 2022) LSCCA T-cell Lymphoma Guidelines (Updated December 2022) LSCCA T-LGL Leukaemia Guidelines (Updated April 2022) LSCCA T-PLL Leukaemia Guidelines (Updated April 2022) Rituximab Jan 2021
Return to header